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ABSTRACT:
The microenvironment of cells controls their phenotype, and thereby the 
architecture of the emerging multicellular structure or tissue. We have reported 
more than a dozen microenvironmental factors whose signaling must be integrated 
in order to effect an organized, functional tissue morphology. However, the factors 
that prevent integration of signaling pathways that merge form and function are still 
largely unknown. We have identified nuclear factor kappa B (NFkB) as a transcriptional 
regulator that disrupts important microenvironmental cues necessary for tissue 
organization. We compared the gene expression of organized and disorganized 
epithelial cells of the HMT-3522 breast cancer progression series: the non-malignant 
S1 cells that form polarized spheres (‘acini’), the malignant T4-2 cells that form large 
tumor-like clusters, and the ‘phenotypically reverted’ T4-2 cells that polarize as a 
result of correction of the microenvironmental signaling. We identified 180 genes that 
display an increased expression in disorganized compared to polarized structures. 
Network, GSEA and transcription factor binding site analyses suggested that NFkB is a 
common activator for the 180 genes. NFkB was found to be activated in disorganized 
breast cancer cells, and inhibition of microenvironmental signaling via EGFR, beta1 
integrin, MMPs, or their downstream signals suppressed its activation. The postulated 
role of NFkB was experimentally verified: Blocking the NFkB pathway with a specific 
chemical inhibitor or shRNA induced polarization and inhibited invasion of breast 
cancer cells in 3D cultures. These results may explain why NFkB holds promise as a 
target for therapeutic intervention: Its inhibition can reverse the oncogenic signaling 
involved in breast cancer progression and integrate the essential microenvironmental 
control of tissue architecture. 
INTRODUCTION
Cancer is an organ specific disease. It is widely 
accepted that the loss of growth regulation is the central 
mechanism shared by all cancers. We have argued that the 
tissue architecture is at least an equally important regulator 
of malignant transformation, and one that may explain 
organ specificity of cancer [1, 2]. Disruption of polarized 
tissue structure [3-5] and induction of cellular invasion 
are accompanied by extensive changes in the cellular 
microenvironment; in many cases the basement membrane 
is degraded, cell-extracellular matrix (ECM) adhesion is 
altered and growth-regulatory signals are lost as a result. 
This microenvironmental remodeling and the consequent 
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changes in tissue structure contribute to the development 
of a malignant phenotype [5, 6]. Over two decades ago 
we developed a 3-dimensional (3D) culture system using 
laminin-rich ECM (lr-ECM) to distinguish normal and 
malignant breast phenotypes [7]. In 3D cultures, non-
malignant HMT-3522 S1 (S1) cells form polarized, 
growth-arrested spheres, which closely resemble the 
alveolar structures of healthy breast tissues referred to 
as acini [8]. We have extended the series to characterize 
premalignant phenotype of additional cell-lines referred 
to as S3 series [9]. We have used these assays to identify 
and characterize the microenvironmental factors and 
signals controlling acquisition of a malignant phenotype 
and its reversal [7, 10-12] (for further references see 
[2]). The isogenic malignant counterpart of S1 cells, the 
HMT-3522 T4-2 (T4-2) cells, display an altered profile of 
microenvironmental receptors and downstream signaling, 
and form disorganized, proliferative structures displaying 
enhanced cell invasion under the same conditions [10, 12] 
(and references cited above).  
In addition to differences in tissue organization, 
compared to their S1 counterparts, the malignant T4-2 cells 
have significantly higher expression of epidermal growth 
factor receptor (EGFR), phosphatidylinositol 3-kinase 
(PI3K), mitogen-activated protein kinase (MAPK) as 
well as beta1-integrin and matrix metalloproteinases 
(MMPs) such as MMP9 among others [5, 9, 10, 12]. 
We have repeatedly shown that by manipulating the 
microenvironmental signals in T4-2 and other malignant 
cells [12], the cells can be induced to form polarized, non-
invasive structures resembling those formed by the non-
malignant S1 cells (‘T4-2R’ cells). We have referred to 
this phenomenon as ‘phenotypic reversion’ [10].  
Decreasing activation of any of the above pathways 
down-modulates their downstream signals, normalizes 
the signaling through all the other pathways and reverses 
the malignant phenotype of T4-2 cells in 3D culture. We 
know also that changes in glucose uptake play an equally 
important role in both disorganization and reversion [13]. 
Thus many seemingly disparate agents and mechanisms 
induce a common phenotypic change (reversion of the 
chaotic malignant phenotype to an organized acinar-like 
structure) if the cells are in a physiologically relevant 3D 
microenvironment. 
This observation led us to hypothesize that 
depending on the microenvironmental signaling, the 
cells must experience changes in their transcriptional 
programs that accompany the observed changes in colony 
architecture. We also hypothesized that there would 
be one or more common transcriptional regulators that 
integrate the signals to effect this switch. To find such 
regulators, we used microarray data of non-malignant S1 
and malignant T4-2 cells, as well as data that had been 
obtained for T4-2 cells ‘phenotypically reverted’ by the 
widest variety of inhibitors, and compared the common 
denominators. These analyses identified the transcription 
factor nuclear factor-kappa B (NFkB) as a prominent 
switch for regulating the change between disorganization 
and polarity in response to microenvironmental changes.
NFkB regulates a number of cancer-related 
processes including immune-response, inflammation, cell 
survival and cancer progression [14]. The NFkB family 
consists of five structurally and functionally conserved 
members in mammalian cells, including RELA (p65), 
RELB (p60), c-REL, NFkB1 (p105 and p50), and NFkB2 
(p100 and p52) [15]. Elevated NFkB binding activity 
has been observed in both primary human breast cancer 
tissues and breast cancer cell lines, and contributes to the 
activation of CYCLIN D1, c-MYC, and MUC1 [16-18]. 
Despite considerable literature suggesting the importance 
of NFkB in cancer in general and in breast cancer in 
particular, the reasons behind its dominant activation 
in tumors are still undefined. We find that NFkB acts 
as a transcriptional rheostat the level of which directs a 
phenotype of order and its aberrant expression spells 
architectural disorder in response to microenvironmental 
changes. This finding could provide a fine-tuning of a 
framework for designing more compelling therapeutics. 
RESULTS
Comparison of malignant disorganized colonies 
with organized acini identified a set of genes 
common in reversion. 
We showed previously that the modification of 
aberrant microenvironmental signaling in malignant 
human mammary epithelial cells (HMECs) reprograms 
them to form polarized, growth-arrested structures in 3D 
cultures [10, 12] (Figure 1A). To identify the alterations 
in gene expression profiles associated with such 
reprogramming events, we utilized microarrays of S1, T4-
2, and T4-2R cells reverted by inhibitors of EGFR, beta1-
integrin, MAPK, PI3K and by broadband inhibitors of 
MMPs as well as by reduced glucose metabolism (Figure 
1B and Supplemental Table 1, GEO database, GSE50444). 
We obtained a gene expression matrix with data from 6560 
genes and 24 microarrays – 5 of S1, 5 of T4-2 and 14 of 
T4-2, reverted with different agents (Supplemental Table 
2). Unsupervised hierarchical clustering analysis showed 
that S1, T4-2 and T4-2R cells each cluster together 
(Supplemental Figure S1). 
We identified a set of 345 genes that were 
differentially expressed in cells with different 3D 
phenotypes – polarized or disorganized - (LIMMA/R 
Bioconductor,p=0.005). The genes upregulated in T4-2 
cells (180 genes) were called ‘disorganization gene 
signature’ (Supplemental Table 3). Genes that were 
upregulated in S1 cells and reverted T4-2 cells (165 
genes) were referred to as ‘organization gene signature’. 
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We used the disorganization gene signature for further 
analysis in order to find transcriptional regulators involved 
in the disturbance of acinar structure in T4-2 cells. The 
expression and hierarchical clustering of these genes is 
depicted in Fig. 1C. 
Using the statistics gene ontology tool DAVID [19], 
we identified genes encoding proteins located in adherens 
junctions and the actin cytoskeleton as well as genes 
involved in processes such as cell adhesion, focal adhesion 
and actin cytoskeleton organization, that were significantly 
enriched in the disorganization gene signature (Figure 
1D). We also found that genes involved in cell migration 
were overrepresented, consistent with a previous report 
correlating disruption of tissue polarity with endothelial 
cell migration [20]. Furthermore, gene set enrichment 
analysis (GSEA, [21]) of the gene expression matrix 
confirmed an increase in expression of actin organization 
in T4-2 cells (p=0.002). 
NFkB associated with the expression of 
disorganization genes.
In order to identify common signaling pathways 
and/or transcription factors involved in the disorganization 
of the 3D structures, we employed several bioinformatics 
tools. Comparison of HMT-3522 expression profiles with 
identified gene sets (Gene Set Enrichment Analysis, [21]) 
revealed that genes related to the ‘positive regulation of 
IKK and NF-κB cascade’ are activated in disorganized 
T4-2 cells (p<0.09, Figure 2A). Using the network analysis 
tool Cytoscape, we identified a regulatory network 
associated with the differentially expressed genes. p65, i.e. 
one of the subunits of NFkB, was one of the major hubs 
of the network with more than 100 neighbors (Figure 2B). 
Most notably, transcription factor binding site analysis of 
the disorganization cluster using TransFind (transfind.sys-
bio.net/, [22]) identified NFkB as a potential transcription 
Figure 1: A cluster of genes revealed by microarray analysis is associated with tissue polarity in HMT3522 cell lines. 
A) Immunofluorescence analysis of basal marker alpha6-integrin in S1, T4-2, and T4-2 cells phenotypically reverted in 3D culture. S1 
and reverted T4-2 cells formed polarized spheroids, but T4-2 cell formed disorganized structures. Blue:DAPI, green: alpha6 integrin. 
Scale: 25µm B) Scheme showing the pathways that were blocked to reverse the malignant phenotypes of T4-2 cells in 3D culture for the 
microarray analysis. C) Unsupervised clustering of the 180 genes upregulated in T4-2 cells as compared to S1 cells and reverted T4-2 
cells. D) Gene Ontology terms (biological processes, cell components, molecular functions) and KEGG pathways overrepresented in the 
disorganization gene signature. 
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factor for the disorganization genes with the third highest 
significance (p<0.005); 24 of the 180 genes were identified 
as potential NFkappaB target genes (Supplemental Table 
3, marked in yellow). This corresponds to a percentage 1.8 
times as high as in the total set of 6560 genes. 
These results suggest that NFkB is a potential 
regulator of the disorganization genes, and that activation 
of NFkB may be associated with disruption of polarized 
mammary tissue structure. 
Figure 2: GSEA and network analyses reveal NFkB as a potential regulator of disorganization genes. A) Gene set 
enrichment analysis [21] finds the gene set ‘positive regulation of IKK and NFkB cascade’ to be enriched among genes that show a 
high expression in unorganized cells (1:’negatively correlated’) and low expression in organized cells in the microarrays (0:’positively 
correlated’) (p=0.09). B)  A regulatory network consisting of the 180 genes of the disorganization signature as well as connecting nodes 
that interact with at least two disorganization genes was identified using Cytoscape. Red nodes: disorganization genes, light blue nodes: 
connecting genes, green edges: interactions found in NCBI, dark blue node: p65.
A B 
Figure 3: The NFkB pathway is activated in disorganized T4-2 cells compared to polarized S1 and reverted T4 cells. A) 
Immunoblotting analysis of p65 expression in S1, T4-2, and reverted T4-2 cells in 3D culture. Laminin A/C was used as a loading control. 
T4-2 cells were reverted by tyrphostin (Tyr), an EGFR inhibitor; LY294002 (LY), a PI3K inhibitor; GM6001 (GM), a MMP inhibitor; 2DG, 
a glucose metabolism inhibitor; VPA, a HDAC inhibitor; AIIB2, a β1 integrin blocking antibody, MAB225 (MAB), an EGFR blocking 
antibody. B) Immunoblotting analysis of phosphorylated p65 in S1, T4-2, and T4-2 cells reverted by tyrphostin. The blot results were 
quantified by AlphaEaseFC software, and expressed as relative levels of phosphorylated p65 to total p65. C) Immunoblotting of nuclear 
protein extracted from S1, T4-2, and T4-2 cells reverted with tyrphostin. D) Luciferase analysis of NFkB transcription activities in T4-2 
and reverted T4-2 cells. Graph displays average ± SEM; n=4.
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Expression and activation of NFkB is associated 
with the disorganized tissue phenotype. 
To confirm that NFkB is indeed activated in 
disorganized MECs compared to polarized cellular 
structures, we assessed the expression of the NFkB 
subunit p65 in S1, T4-2, and reverted T4-2 cells. We found 
that mRNA levels of p65 were significantly upregulated 
in disorganized T4-2 cells compared to polarized S1 
cells or reverted T4-2 cells. Interestingly, p65 is one of 
the 180 genes of the disorganization signature in T4-2 
cells (Supplemental Figure S2). Among the 25 genes 
with the highest correlation of expression with p65, there 
were three genes involved in ECM-receptor interaction, 
alpha6-integrin, beta4-integrin and thrombospondin 
(with correlation coefficients of 0.91, 0.87 and 0.86 
respectively), indicating a tight connection between 
their expression and p65 (data not shown). p65 was also 
increased at the protein level in untreated T4-2 cells 
compared to S1 cells. Reversion of T4-2 cells by blocking 
of EGFR, beta1-integrin, MMP, and their downstream 
signals drastically reduced the expression of p65 in those 
cells (Figure 3A), suggesting that microenvironmental 
cues contribute to NFkB activation in the disorganized 
HMECs. 
It has been reported that p65 is phosphorylated at 
Ser536 by IkappaB kinase (IKK), NFkB activating kinase, 
and Ribosomal S6 kinase 1 (RSK1), which in turn induces 
nuclear translocation of p65 [23]. Thus, we analyzed the 
phosphorylation at Ser536 and nuclear levels of p65. 
Quantification of immunoblotting results showed that 
Ser536 phosphorylation of p65 was increased in T4-2 cells 
and repressed in S1 and reverted T4-2 cells (Figure 3B). 
In addition, nuclear translocation of p65 was consistent 
with phosphorylation status (Figure 3C). In order to 
assess the NFkB activity in T4-2 and reverted T4-2 cells 
directly, we measured the luciferase activity in cells stably 
transfected with a luciferase reporter construct that is 
controlled by NFkB response elements. We found that 
the transactivation activities of NFkB were significantly 
reduced in T4-2 cells reverted by the EGFR inhibitor 
(Figure 3D). In summary, we find the malignant phenotype 
associated with higher levels of p65 mRNA, p65 protein 
levels as well as increased NFkappaB transcriptional 
activity. 
Figure 4: Inhibition of the NFkB pathway reverses the malignant phenotypes of T4-2 cells in 3D culture. A) Phase 
and immunofluorescence images of T4-2 cells. Cells were either treated with NFkB inhibitor (Wedelolactone, 10 µM) and cultured in 
3D for four days orinfected with p65 shRNA lentivirus before plating in 3D culture. Blocking the NFkB pathway reprograms the cells to 
form polarized spheroids structure. Green: alpha6-integrin. Scale: 25µm.  B)  Immunoblotting analysis of beta1-integrin, EGFR and p65 
expression in control and p65 shRNA-expressing T4-2 cells. C) Transwell invasion analysis of control and p65 shRNA-expressing T4-2 
cells. Graph displays average ± SEM; n=3. D) Quantification of mRNA levels of NFkB target genes by real-time PCR. Control and p65 
shRNA-expressing T4-2 cells were cultured in 3D for 4 days before RNA extraction. 
Phase           α6 integrin     
p6
5 
sh
   
   
   
N
F-
κB
I  
   
   
   
  C
tr
l
Ctrl   p65sh
EGFR
β1-integrin
LAMA/C
p65
0
500
1000
1500
2000
In
va
de
 c
el
ls 1.2k
0.4k
0
20
40
60
80
100
120
T4-vector
T4-shp65
R
el
at
iv
e 
m
R
N
A 
le
ve
l 1.0
0.6
0.2
A
B
C D
T4-2-vector control 
T4-2-shp65 
Phase           α6 integrin     
p6
5 
sh
   
   
   
N
F-
κB
I  
   
   
   
  C
tr
l
Ctrl   p65sh
EGFR
β1-integrin
LAMA/C
p65
0
500
1000
1500
2000
In
va
de
 c
el
ls 1.2k
0.4k
0
20
40
6
80
100
120
T4-vector
T4-shp65
R
el
at
iv
e 
m
R
N
A 
le
ve
l 1.0
.6
0.2
A
B
C D
T4-2-vector control 
T4-2-shp65 
Phase           α6 integrin     
p6
5 
sh
   
   
   
N
F-
κB
I  
   
   
   
  C
tr
l
Ctrl   p65sh
EGFR
β1-integrin
LAMA/C
p65
0
500
1000
1500
2000
In
va
de
 c
el
ls 1.2k
0.4k
0
20
40
60
80
100
120
T4-vector
T4-shp65
R
el
at
iv
e 
m
R
N
A 
le
ve
l 1.0
0.6
0.2
A
B
C D
T4-2-vector control 
T4-2-shp65 
Oncotarget 2013; 4:2015www.impactjournals.com/oncotarget
Downmodulation of NFkB leads to phenotypic 
reversion. 
To show that inhibition of NFkB indeed leads to 
phenotypic reversion, we blocked NFkB activation in 
T4-2 cells by two means. T4-2 cells cultured on top of 
3D laminin-rich ECM (lrECM) gels for four days were 
treated with Wedelolactone, an IKK inhibitor [24].
The Wedelolactone-treated cells formed small spheroid 
structures with basal polarity (alpha6-integrin), whereas 
the vehicle-treated control cells remained as disorganized, 
larger structures (Figure 4A). We also utilized shRNA to 
reduce p65 expression in T4-2 cells (Figure 4B). Reducing 
p65 expression reprogrammed T4-2 cells to form polarized 
spheroids structures in 3D cultures (Figure 4A), and cell 
invasion was significantly suppressed (Figure 4C). Using 
quantitative RT-PCR, we measured several NFkB -targeted 
genes to compare the NFkB activity in control vs. p65 
knockdown cells. Our results showed significant reduction 
in mRNA levels of SERPINA1, TNFSF12A, PLAT, DUSP, 
MMP19, and TNFSF9 after downregulation of p65 (Figure 
4D). As expected from our previous data, we found that 
the protein levels of beta1-integrin and EGFR were also 
decreased in p65 knockdown cells (Figure 4B). NFkB 
provides a ‘disintegration node’ in a 3D tissue-like setting. 
The expression of the disorganization genes 
correlates also with the phenotype of other breast 
cancer cell lines in 3D.
The 3D morphologies of a substantial panel of 
human breast cancer cell lines correlate with their 
gene expression profiles in 3D cultures and tumor 
cell invasiveness [25]. Since mRNA levels of the 180 
disorganization genes are associated with tissue structure 
in the HMT-3522 cell lines, we sought to determine 
whether these genes are similarly associated with 3D 
morphologies of other breast cancer cell lines. Comparing 
the average expression of the disorganization genes in 24 
breast cancer cells lines, we found a higher expression in 
basal cell lines than in luminal cell lines (Supplemental 
figure S3). Unsupervised hierarchical clustering analysis 
of the disorganization gene set revealed a correlation of 
expression with subtype as well as 3D morphology. Basal 
B cell lines clustered together with higher expression of 
disorganization genes compared to luminal cell lines. 
Within the basal B cluster (I), the majority of the cancer 
cells with stellate morphology grouped together (Figure 
Figure 5: Expression of disorganization genes and activation of the NF-κB pathway are associated with aggressive 3D 
phenotypes of multiple breast cancer cell lines. A) Unsupervised hierarchical clustering of breast cancer cell lines in 3D culture 
using the 180 disorganization genes. Each row represents a gene; each column represents a cell line. B) Bar graph of RelB mRNA levels 
in basal and luminal types of breast cancer cell lines. RelB mRNA expression is assessed by Affymetrix microarray and measured as log2 
(probe intensities). C) Phase and immunofluorescence images of BT549 cells. Cells were either treated with Wedelolactone in 3D culture 
for 4 days or infected with RelB shRNA retrovirus before being seeded in 3D culture. D) Transwell invasion analysis of BT549 cells. The 
cells were treated with NF-κB inhibitor (Wedelolactone, 10 µM) or transfected with RelB shRNA vector. 
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5A). Most of the cell lines in the second cluster (II) are 
luminal and basal A subtypes with spheroid 3D, mass 
or grape-like phenotypes. The majority of basal B cells 
form stellate structure in 3D culture and lack E-cadherin 
expression, reflecting decreased cell–cell interactions and 
enhanced invasion [25]. Therefore, the up-regulation of 
disorganization genes seems associated with aggressive 
morphologies and increased cell invasion in 3D cultures.  
To examine whether NFkB activity is functionally 
involved in the 3D phenotypes of other breast cancer 
cell lines, we chose BT549, a basal cancer cell line with 
a stellate morphology. It was treated with Wedelolactone 
in 3D culture. Most of the Wedelolactone-treated cells 
formed round or mass structures in 3D lrECM gels 
(Figure 5C). The colony structures were more organized 
in drug-treated cells as shown by beta-catenin and nuclear 
staining, although the metastatic cells were not fully 
polarized (Figure 5C), as was the case for MDA-MB-231 
cells which require more than one inhibitory factor to 
be fully reverted [12]. The dramatic changes in tissue 
structures were accompanied by a significant reduction 
in cell invasion (Figure 5D). Since mRNA levels of the 
NFkB subunit  RELB are elevated in basal-type breast 
cancer cells (Figure 5B), NFkB signals in those cells can 
also be blocked with shRNA targeting the RELB gene. 
We found that in 3D culture, RELB-silenced BT549 cells 
form structures with reduced invasive branches which 
we termed ‘mass’ (Figure 5C and supplemental Figure 
S4) [25] . In addition, knockdown of RELB significantly 
inhibited invasion of BT549 cells (Figure 5D). These 
results indicate the involvement of NFkB pathway in 
invasion of basal-type breast cancer cells in 3D gels. 
DISCUSSION  
Loss of tissue organization is a trait of every 
malignant tumor, but growth rather than architecture 
has traditionally been accepted to be the most important 
hallmark of cancer. Yet for more than a decade we have 
shown repeatedly that the architecture of the breast 
acini in 3D cultures can be dominant over the malignant 
genome, i.e. the cancer cell phenotype and growth status 
can be reversibly altered if the architecture is restored via 
microenvironmental signaling [1, 2]. This reversibility 
in the absence of genetic changes [26] implies that 
the phenotype is linked to the regulatory status and 
relatively unaffected by the genetic composition of the 
cells. Interestingly, within the same malignant cells, the 
inhibition of many different signaling pathways leads to a 
similar organized phenotype [3] . Because of reversibility 
and commonality of phenotype, we postulated that the 
dramatic change seen with multiple reverting agents could 
indicate the existence of specific molecular ‘nodes’ that 
control architectural reorganization in response to this 
great variety of microenvironmental factors.
Our analyses revealed that the extensive common 
differences in the gene expression profile of cells 
with an organized and disorganized phenotype in 
mammary epithelial cells are associated with at least one 
transcriptional regulator, NFkB. This makes NFkB one of 
the critical nodes through which the microenvironmental 
signaling pathways pass/integrate. When NFkB is 
suppressed, the architecture is maintained and tissues 
remain functional. Should the microenvironmental 
signaling be disrupted, NFkB becomes activated, and both 
tissue polarity and normal functions become imbalanced. 
Figure 6: A scheme showing the role of NF-κB as potential integrator of various microenvironmental cues and regulator 
of multicellular organization. 
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In our studies blocking NFkB with a chemical inhibitor 
or shRNA was sufficient for the reestablishment of basal 
polarity in malignant cells; conversely in all conditions 
where malignant breast cancer cells were ‘reverted’, NFkB 
levels were decreased.
NFkB  has been shown to be involved in the 
development and progression of breast cancer: It is 
frequently highly activated in mammary tumors, in 
particular within disorganized ER-negative tumors where 
it has been reported to promote cancer progression by 
enhancing cancer cell survival and proliferation [27, 28]. 
To this list we now add an additional important function 
of NFkB as an important player in loss of tissue polarity 
and organization. It was shown previously that modulation 
of many different oncogenic pathways including EGFR, 
PI3K and integrin signaling leads to changes in NFkB 
activity [29-35]. Also, activation of the NFkB pathway 
is required for induction and maintenance of EMT 
in mammary tumors [36]. In our 3D model, down-
modulation of all these pathways leads to a reorganized 
phenotype, and our analysis suggests that NFkB is a 
major molecular linker between these pathways and 
tissue architecture: Of the 24 genes that are upregulated 
in disorganized cell clusters and that have potential NFkB 
binding sites in their promotor region (Supplemental 
Table 3, marked in yellow), four genes were associated 
with actin cytsoskeletal organization, cell junction and cell 
adhesion in the GO database (ACTN1,EPB41L2, GNE, 
PANX1).  
This has strong implications for NFkB in cancer 
prevention and as target for therapeutic efforts: If 
keeping NFkB balanced is the key to healthy mammary 
tissues, signaling gone awry in malignant cells can be 
compensated through reducing other stimuli activating 
NFkB, including reductions in stress and inflammation. As 
long as NFkB is high, integration of the aberrant signaling 
cannot be restored to normal levels. As a consequence, 
compensatory signaling pathways can be easily activated 
in cells that have become imbalanced. We suggest that 
inhibition of NFkB in breast cells could be one crucial 
change that would allow these cells to reorganize and 
thereby to re-integrate their signaling.  The additional 
details of how exactly the microenvironmental signals 
reach NFkB and what are the other arms by which the 
switch occurs require further investigation. 
MATERIALS AND METHODS
Cell culture. 
HMT-3522 S1 and T4-2 cells were maintained on 
tissue culture plastic as previously described [7]. BT549 
cells were propagated in DMEM/F12 (Sigma) with 10% 
fetal bovine serum (Invitrogen). Three dimensional 
laminin-rich extracellular matrix (3D lrECM) on-top 
cultures [37] were prepared by trypsinization of cells from 
tissue culture plastic, seeding of single cells on top of a 
thin gel of Engelbreth-Holm-Swarm (EHS) tumor extract 
(Matrigel: BD Biosciences; Cultrex BME: Trevigen), and 
addition of medium containing 5% EHS. S1 cells were 
seeded at a density of 3.1×104 cells per cm2; T4 and BT549 
cell lines were seeded at 2.1 ×104 cells per cm2. S1 and 
T4-2 were maintained in their propagation medium with 
media change every 2 days. BT549 cells were maintained 
in H14 medium [7] with 1% fetal bovine serum. 
Microarray hybridization and analysis.
S1, T4-2 and reverted T4 cells were isolated from 
3D cultures with PBS/EDTA as previously described [37]. 
Purified total cellular RNA was extracted using RNeasy 
Mini Kit with on-column DNase digestion (Qiagen). 
RNA was quantified by measuring optical density at A260 
and quality was verified by agarose gel electrophoresis. 
Affymetrix microarray analysis was performed using the 
Affymetrix HG-U133A High Throughput Array (HTA) 
GeneChip system, generating two sets of data from two 
separate array platforms (GPL3921 and GPL4685, GEO 
database GSE50444). Preprocessing, normalization and 
filtering was performed using R Bioconductor [38].MAS5 
normalization was performed separately on the two sets of 
expression data. ProbeIDs were filtered out if the average 
log2 expression value was lower than 6.5. For genes with 
more than one probeID, we only considered the one with 
the highest variance. The two sets of expression values 
were row-centered (mean and variance) separately and 
then merged to one gene expression matrix. Unsupervised 
hierarchical clustering analysis was performed with 
Cluster (uncentered correlation, average linkage), and 
results were visualized with TreeView (http://www.
eisenlab.org/eisen/?page_id=42). Gene set enrichment 
analysis was performed with GSEA v2.07 (http://www.
broadinstitute.org/gsea/index.jsp, [21]). Network analysis 
was performed with Cytoscape 2.7.0. Transcription factor 
binding site analysis was performed using TransFind (-300 
to 100 bp, top 500 genes, [22]). Potential targets of NFkB 
transcriptional regulation were retrieved by repeated 
transcription factor binding site analysis with subsets of 
the disorganization signature using Transfind. DAVID 
Gene Ontology was used to determine overrepresented 
GO and KEGG terms [19]. 
Virus production and transduction. 
For p65 shRNA production, a double-stranded 
DNA oligonucleotide was generated from the following 
sequences: sense,5’-GATCCGGACATATGAGACCTT
CAACTTCCTGTCAGATATATCTCTCCTTCCACAC
TTTTTG-3’; antisense,5’-AATTCAAAAAGGACATAT
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GAGACCTTCAATCTGACAGGAAGTATATCTCTCC
TTCCACACG-3’ (target sequence underlined; BamH1/
EcoR1 cohesive ends italicized). Both oligonucleotides 
were annealed and ligated into BamH1/EcoR1 site 
of pGreen puro lentival vector (System Biosciences). 
Lentivirus production and transduction of target cells were 
conducted following guideline by System Biosciences. 
Briefly, lentivirus vector and packaging plasmid mix 
(System Biosciences) were transfected into 293FT cells 
(Invitrogen) using Lipofectamine® 2000. After 48 hours, 
medium was harvested, filtered and used to infect target 
T4-2 cells with the addition of polybrene (10 µg/ml). After 
24 hours medium was replaced. At 72 hours post-infection 
puromycin (0.5 µg/ml) was added for selection and 
maintained throughout the culturing period. shRNA vector 
against RelB were from Open Biosystems. Retrovirus 
production and infection protocol from the company were 
followed. 
Immunofluorescence and image acquisition. 
Cells in lrECM gel were smeared on slides, 
dried briefly, and fixed with 4% paraformaldehyde 
and permeabilized with 0.5 % Triton X-100. Stained 
samples were imaged using a Spot RT camera attached 
to a Zeiss upright epifluorescence microscope or a 
Stanford Photonics XR/Mega-10 ICCD camera attached 
to a Solamere Technology Group (Salt Lake City, UT) 
spinning disk confocal system comprised of a Zeiss 
Axiovert 200M inverted microscope. Pictures were taken 
using a 63×oil immersion objective with QED InVivo 
imaging software at room temperature. The digital images 
were pseudocolored, overlayed and merged using ImageJ 
1.38 or Adobe Photoshop 7.0. 
RT-PCR and real-time PCR.
Total RNA was extracted from cells using RNeasy 
Mini Kit (Qiagen). cDNA was synthesized using 
Superscript first strand synthesis kit (Invitrogen) from 
0.5-1.0 μg RNA samples. Quantitative real-time PCR 
analysis was performed with the Lightcycler System using 
the Lightcycler FastStart DNA Master SYBR Green I kit 
(Roche). The following Lightcycler PCR amplification 
protocol was used: 95°C for 10 min (initial denaturation), 
and 45 amplification cycles (95°C for 5 s, 60°C for 10 
s, 72°C for 5 s). Amplification was followed by melting 
curve analysis to verify the presence of a single PCR 
product [39].
Luciferase assays and western blot analysis. 
Three copies of NF-κB response element were 
linked to TK minimal promoter and cloned into a reporter 
vector pGL3 (Promega). T4-2 cells were co-transfected 
with pGL-NF-κB and pNeo plasmid (1:10). Stably 
transfected cells were isolated by G418 selection and 
cultured in 3D in the presence of Tyrphostin. Following 
treatment, equal amounts of cell lysates were assayed for 
luciferase activity.
S1 and T4-2 cells were cultured in 3D for 10 days. 
Total and nuclear protein was extracted from S1, T4-2, and 
reverted T4 cells or nuclei. Western blot experiments were 
performed as previously described [40]. After sonication, 
insoluble material was removed by centrifugation at 15,000 
g for 10 min. Proteins (20 µg) from each sample were 
subjected to SDS gel electrophoresis and then transferred 
to nitrocellulose membrane (Schleicher & Schuell). The 
membrane was subsequently incubated in blocking buffer 
containing primary antibody and horseradish peroxidase-
conjugated secondary antibodies. The membrane was then 
subjected to enhanced chemiluminescence (ECL) using 
the SuperSignal chemiluminescent substrate (Pierce, 
Rockford, IL).
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